Eli Lilly Aktie
728,70
EUR
±0,00
EUR
±0,00
%
757,50
USD
+0,07
USD
+0,01
%
nachbörslich
Eli Lilly Aktie Analyse
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
05.10.18 | Eli Lilly Outperform | BMO Capital Markets | |
25.07.18 | Eli Lilly Neutral | Goldman Sachs Group Inc. | |
08.06.18 | Eli Lilly Overweight | Cantor Fitzgerald | |
13.04.18 | Eli Lilly Market Perform | BMO Capital Markets | |
16.01.18 | Eli Lilly buy | Jefferies & Company Inc. | |
27.04.17 | Eli Lilly Hold | Argus Research Company | |
Werbung
|
|||
21.04.17 | Eli Lilly Underperform | BMO Capital Markets | |
07.04.17 | Eli Lilly overweight | Barclays Capital | |
20.03.17 | Eli Lilly Neutral | UBS AG | |
07.12.15 | Eli Lilly Buy | Deutsche Bank AG | |
01.12.15 | Eli Lilly overweight | Barclays Capital | |
20.11.15 | Eli Lilly Outperform | BMO Capital Markets | |
22.07.15 | Eli Lilly Equal weight | Barclays Capital | |
18.06.15 | Eli Lilly Buy | Argus Research Company | |
08.01.15 | Eli Lilly Hold | Deutsche Bank AG | |
08.01.15 | Eli Lilly Neutral | UBS AG | |
02.07.14 | Eli Lilly Equal weight | Barclays Capital | |
03.07.13 | Eli Lilly kaufen | Citigroup Corp. | |
28.05.13 | Eli Lilly halten | Jefferies & Company Inc. | |
03.12.12 | Eli Lilly buy | Citigroup Corp. | |
13.11.12 | Eli Lilly outperform | Credit Suisse Group | |
15.10.12 | Eli Lilly underperform | Jefferies & Company Inc. | |
10.10.12 | Eli Lilly neutral | Goldman Sachs Group Inc. | |
09.10.12 | Eli Lilly neutral | UBS AG | |
01.10.12 | Eli Lilly neutral | UBS AG | |
01.10.12 | Eli Lilly kaufen | Die Actien-Börse | |
21.09.12 | Eli Lilly neutral | UBS AG | |
06.09.12 | Eli Lilly outperform | Sanford C. Bernstein and Co., Inc. | |
28.08.12 | Eli Lilly neutral | UBS AG | |
28.08.12 | Eli Lilly outperform | Credit Suisse Group | |
01.08.12 | Eli Lilly neutral | Credit Suisse Group | |
31.07.12 | Eli Lilly neutral | JP Morgan Chase & Co. | |
21.06.12 | Eli Lilly neutral | Credit Suisse Group | |
12.01.12 | Eli Lilly neutral | UBS AG | |
10.01.12 | Eli Lilly hold | Jefferies & Company Inc. | |
27.10.11 | Eli Lilly neutral | Citigroup Corp. | |
15.09.11 | Eli Lilly overweight | Barclays Capital | |
25.07.11 | Eli Lilly neutral | UBS AG | |
19.07.11 | Eli Lilly hold | Citigroup Corp. | |
12.07.11 | Eli Lilly hold | Citigroup Corp. | |
30.06.11 | Eli Lilly hold | Citigroup Corp. | |
01.06.11 | Eli Lilly hold | Citigroup Corp. | |
30.05.11 | Eli Lilly equal-weight | Barclays Capital | |
16.05.11 | Eli Lilly kaufen | Die Actien-Börse | |
20.04.11 | Eli Lilly equal-weight | Barclays Capital | |
15.04.11 | Eli Lilly equal-weight | Barclays Capital | |
07.03.11 | Eli Lilly equal-weight | Barclays Capital | |
31.01.11 | Eli Lilly equal-weight | Barclays Capital |